dr. d’abreo on extended therapy trials in breast cancer
Published 4 years ago • 334 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
6:55
extended adjuvant therapy for her2 early breast cancer
-
1:59
dr. melisko reflects on findings from the mindact trial in breast cancer
-
10:02
breast cancer: extended adjuvant endocrine therapy
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
1:13
dr. mamounas on the role of extended adjuvant endocrine therapy in er breast cancer
-
1:09
dr. rao on the soft trial in patients with premenopausal breast cancer
-
4:01
duration of endocrine therapy in breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
2:08
dr. gorantla on the impact of the aphinity trial in her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
1:23
brock schroeder discusses bci findings in er breast cancer
-
1:47
dr. borgen discusses trials in neoadjuvant her2 breast cancer
-
0:59
dr. burstein on the results of the apt trial for her2 breast cancer
-
1:15
dr. burstein on the follow-up of apt trial for her2 breast cancer
-
5:01
neoadjuvant lapatinib in her2 early breast cancer
-
5:45
evaluating and managing comorbidities in early breast cancer